Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merlot OrthopediX Inc.

www.merlotorthopedix.com

Latest From Fujisawa Pharmaceutical Co. Ltd.

Astellas Dips Into Digital Health Via New Venture

New venture DigiTx will give Astellas a leg up in its quest to access novel digital health technologies, in a move unveiled as the Japanese firm reported continued strong growth for top product Xtandi.

Commercial Deals

Deals of the Week: Options Abound As Forest Keeps Its Eyes On A Prize-Winner

Reflecting a long trend, three of this past week’s deals include option arrangements, including one with a new twist. Also, a rare disease partnership between Shire and Atlas Venture finally leads to a deal and Takeda continues building its vaccines business.

BioPharmaceutical Deals

Drais In Third Deal With Astellas, Seeks To Expand Partnership Model

Astellas has returned for a third time to enlist the development services of Drais, out-licensing a nocturia candidate which Drais will house in a virtual development company, Tacurion. Drais’ challenge now is to expand its portfolio of single-asset companies and its roster of investors.

Deals Strategy

Moving Beyond Accutane and Botox

Ever hungry for new investment opportunities, VCs are now backing start-ups developing novel dermatology products for both medical and cosmetic conditions. These aren't your typical "derm" companies. Not content to invent new delivery vectors for existing medicines or reformulate them into more patient friendly creams, these fledgling companies are trying to develop new chemical entities based on novel skin biology.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merlot OrthopediX Inc.
  • Senior Management
  • Paul Erickson, Sr. Mgr., Product Dev.
  • Contact Info
  • Merlot OrthopediX Inc.
    Phone: (440) 266-8220
    Cleveland, OH
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register